Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2000

View Archived Issues

Corixa's leishmaniasis vaccine program receives additional funding

Neurocrine Biosciences reports results of phase II trial with NBI-5788 in MS

Serotonergic receptor ligands under study at Cerebrus for obesity and other disorders

New LHRH antagonists in the Abbott pipeline

New compounds from Japanese lab inhibit Th2-type cytokine production

Forbes Medi-Tech initiates phase II trial for CardioRex

Patent claim allowance for LCG-MAb received by Cytoclonal

Updated results from G-3139 clinical trial demonstrate durable response and survival

Health Canada approves Rituxan for treatment of NHL

Fuji Chemical prepares new peptides for the treatment of pain

AstraZeneca develops new class of MMP inhibitors with selectivity for MMP-13, MMP-9

Aminoalcohol-based beta3-agonists claimed by Fujisawa for incontinence, pollakiuria

Recent patent covers Merck's new tyrosine kinase inhibitors

Biological effects of SU-9516, a cdk inhibitor, studied in human colon cancer cells

Novel tumor-targeting approach taken by McGill scientists using chimeric molecules

Full human genome is sequenced for the first time

NewBiotics completes private placement and prepares to advance study of lead product

Nonsecosteroidal, nonhypercalcemic VDR agonist with antitumor activity designed at Ligand

Positive preclinical data obtained for naked DNA prostate cancer vaccine

NitroMed searches for new, more effective treatments for MED: nitrated PGE1 analogues

More stable antimalarial aminoquinolines sought by Tulane investigators

Teva completes acquisition of Novopharm

Fujisawa's COX-2 inhibitor FK-3311 protects against I/R injury in lung transplantation

Alexion to commence phase Ib pilot study of 5G1.1 in pemphigoid patients

Catechin consumption protects against atherosclerosis in mouse model

Synthetic factor Xa inhibitor better than LMWH in rat model of DIC

Boston Life Sciences initiates phase II testing of Altropane in ADHD diagnosis

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...